Member Info for Gheko

Nope and now the lights can be turned off. What an absolute shambles.

Says something about TEK putting top management in place!!

US National Cancer Institute due to agree continuation of collaboration with FAB but now on commercial terms.

Optimal launch just a few weeks away too so expecting more deals announced around the same time.

All aboard 🚀🚀🚀🚀

Hope Jamaica recovers quickly from the storm and that all folk are ok 🙏.

The moving towards operational phase now for UOG could add massively to the Jamaican economy with the huge discovery waiting to be uncovered. Now is the time for UOG and it’s happening very soon.

Great post BillyRay. Sums up the enormous short term potential here.

Nice 2x circa £90k buys this afternoon.

Wakey Wakey those looking for the next rocket 🚀🚀🚀 Market micro cap of £3.5 million at moment so upside is truly huge.

If you view the excellent presentation from Adrian posted yesterday regarding their world class work on antibodies then look at the value big pharma put on even early stage antibody discoveries then you will see why FAB is going to re rate massively soon or be taken out by a major. As an example look below at what GSK is willing to pay for an antibody used in prostate therapy…£200 million plus!!

GSK has signed a deal for commercialisation of the drug from Syndivia, a biotechnology company based in Strasbourg, as the FTSE 100 group builds out its pipeline in one of the final deals under its outgoing chief executive Dame Emma Walmsley.

Syndivia specialises in the creation of a class of drugs known as antibody-drug conjugates, which link a chemotherapy drug to an antibody to help target specific proteins on the surface of a cell.

GSK said in a statement that Syndivia's preclinical drug has shown “enhanced anti-tumour activity” and “an encouraging safety profile”, enabling it to shrink tumours without causing an increase in side-effects. GSK is making an upfront payment to Syndivia as part of the agreement, with further payments depending on the success of the drug's development.

Another nice trial RNS but what about the funding situation.? On 9th Octobervteh Company said this remember,”

In the event that the Conditional Placing and the Retail Offer do not complete the Company's cash runway is very limited, and it is highly likely that the Company would in the coming weeks be required to take steps in order to protect the interests of, inter alia, creditors of the Company, with these actions likely materially impacting shareholder value. Further, in such circumstances the Company believes it is likely that key members of staff may seek alternative employment given the significant uncertainty over the Company's future and the Company's ability to make new hires into the business will also be significantly hampered. The Company's standing with its suppliers, collaborators and customers is also likely to be materially impacted negatively;

It is a few weeks on so if that statement was true and accurate then the board will need to take steps imminently to protect creditors etc to the detriment of shareholders.

No wonder the the initial enthusiasm is ebbing away from this RNS. Gamble of a share with total wipeout possibility in short order.

Awesome interview and with Optimal launch now imminent then the re rate will start in earnest. Upside is huge!!

Resolutions passed so company has raised the funds plus warrants will bring in more funds due course.

Full steam ahead now with the imminent survey and farm out talks. Hold tight this should be an exciting ride 🚀🚀🚀

Not concerned. It will pass as always in the Caribbean. Worked out there and they very good at clearing up quickly afterwards.

Not going to affect the massive resource underground!

Onwards and upwards

Due today on the general meeting being held. Hopefully all goes smoothly and then the company is off and running with the piston core survey and farm out talks we will be in a much stronger position.

Most exciting time for this company. Good luck all.

The deal with the US National Cancer Institute ends in November ie from next Saturday onwards.

This massive highly respected organisation has been trialling our Oltimal system for two years and the company have said they wish to continue but this time will need to be on commercial terms.

So first deal for Optimal imminent which will re rate the shares accordingly and then the formal launch of Optimal to the wider market the month following in December at the highly regarded conference of the biggest names in the industry.

Standby for news on top of news and the rockets under the share price 🚀🚀🚀🚀

Oh, and as an aside , due diligence being done in Optipharge by a company potentially wanting a licensing deal. Bring on the news.

Quality appointment to the board ahead of finalisation of fund raise on Monday and then it’s all news with the survey coming up and ongoing farm out talks which could land at any time.

No wonder he has agreed to join the board now. All aboard.

With the commercial launch of Oltimal now imminent and the showcase conference coming up with all the big players in the industry attending it is interesting to see what can happen to the share price when the news drops.

Take IMM which today announced new website and discussions with potential partners and the share price up 26%.

Our turn coming very soon with the Optimal launch and partner deals. IMM has a market cap of circa £64 million. By comparison FAB has a tiny market cap and the upside is therefore huge.

All aboard for the imminent action coming. 🚀🚀🚀

When you have got such huge mineralisation and gold results you need a big calculator to work it all out before RNSing it.

Plus they probably scratching their heads going “Oh my days, this is huge, can it really be right. Yep it is!” 🚀🚀🚀🚀

The company needs referring to the FCA for investigation into its corporate governance failings.

On 12th September they put out an RNS stating inter alia “ If the Fundraising does not proceed as set out above in the next few days the Company will be unable to meet its immediate cash requirements”.

Since then there has been no update for the past 5 weeks. The statement made on 12th September was crystal clear that if no fund raise in next few days (ie being generous say 5 days?) then it would be unable to meet its cash requirements and therefore is presumably effectively insolvent.

Either that statement was misleading to the market or the company have failed in its duty to further update the market if there has been a material change in circumstances since making that statement. Disgraceful behaviour by the board imho.

Me too Stan, £6k, £3k and £2k. Then price moved up.

Next assault on the 20p chart target coming followed by blue sky up to 32p.

NCI contract could be as early as next week then 🚀🚀🚀🚀

First prediction of the day right then. Now blue.

Next prediction - deal with US NCI with good recurring revenue.

Well done those getting some at the bargain price this morning. Another assault on the 20p target coming. 🚀🚀🚀🚀

Did folk read the RNS in a foreign language they didn’t understand!!

Excellent update. Confirmed again that US National Cancer Institute want to carry on using our services where the current agreement runs out next month. This time however we are looking st it in a commercial basis!

Add to that the enthusiasm behind the launch of Optimal shortly plus other pipeline deals coming through and you will see that those of us buying in this morning on the ludicrous drop will be in tidy profit by close and can see a blue finish once folk read the news properly.

Upside here is very healthy indeed in the short term.

CEO presenting on Thursday setting out the exciting period of news ahead with the survey work and ongoing farm out discussions.

Upside here is phenomenal. 🚀🚀🚀🚀

I agree, I think as I have said that the companies in data room are going to make a move soon to secure this potential huge opportunity.

News going to come thick and fast that’s why I’m not with you Toby in suggesting waiting for the placing to complete. That’s in the bag and for the sake of 1/4 point here or there the opportunity to get in now and enjoy the ride is more compelling than sitting on the sidelines. Once the farm out news hits then the placing price will seem like a golden egg everyone should have grabbed! Good luck all.